Centene (CNC)
Healthcare · Medical - Healthcare Plans
10 members of Congress have disclosed 30 trades in Centene (CNC) since 2023: 20 buys and 10 sales. The most recent was disclosed on Oct 7, 2026.
- Trades disclosed
- 30
- Members trading
- 10
- Buys / sells
- 20 / 10
- Reported value
- $269K–$1M
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at CNC
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure
The Department is issuing a final regulation that will require providers of pharmacy benefit management services and affiliated providers of brokerage and consulting services to disclose information about their compensation to fiduciaries of large, self-insured group health plans subject to the Employee Retirement Income Security Act (ERISA). Pharmacy spending is a major driver of overall healthcare costs for employers and is growing faster than medical and surgical spending. These disclosure requirements apply for purposes of ERISA's statutory prohibited transaction exemption for service arrangements under section 408(b)(2). These disclosures are needed so that fiduciaries can assess the reasonableness of contracts or arrangements with these service providers, including the reasonableness of the service providers' compensation. As directed in section 12 of President Trump's Executive Order 14273, Lowering Drug Prices by Once Again Putting Americans First, the Department is issuing this rule to improve employer health plan transparency into the direct and indirect compensation received by pharmacy benefit managers. This final rule will affect sponsors and other fiduciaries of large, self-insured group health plans and certain service providers to such plans.
CNC: Financial results
Filed 8-K for an event or period dated 2026-10-27. Financial results.
CNC: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
CNC: third_quarter 2026 lobbying report
Strategic guidance and counsel related to Medicare, Medicaid, and the insurance market.
Public: Oct 20, 2026, 2:22 PM EDTOriginal source ↗CNC: third_quarter 2026 lobbying report
Issues related to health insurance and affordability. Issues related to Medicaid, Medicare Advantage, behavioral health and prior authorization.
Public: Oct 20, 2026, 12:28 PM EDTOriginal source ↗
Who traded CNC
- Rep. Tim Moore (R-NC-14)8 buys · 1 sale81Sep 3, 2025
- Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)2 buys · 2 sales22Sep 12, 2025
- Rep. Kathy E. Manning (D-NC-6)4 buys · 0 sales40Aug 16, 2024
- Rep. Daniel S. Goldman (D-NY-10)2 buys · 2 sales22Aug 13, 2023
- Rep. Julia Letlow (R-LA-5)1 buy · 1 sale11Jan 13, 2026
- Rep. Jefferson Shreve (R-IN-6)1 buy · 1 sale11Jun 22, 2025
- Rep. Robert P. Bresnahan, Jr. (R-PA-8)1 buy · 1 sale11Jun 9, 2025
- Rep. Ro Khanna (D-CA-17)0 buys · 1 sale01Oct 7, 2026
- Rep. Val T. Hoyle (D-OR-4)1 buy · 0 sales10Sep 12, 2025
- Rep. Earl Blumenauer (D-OR-3)0 buys · 1 sale01Jul 12, 2023
All trades
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
$1K–$15K · Traded Aug 8, 2025 · disclosed Jan 13, 2026 · filed 158 days later
- Jan 13, 2026$1K–$15K
Rep. Julia Letlow (R-LA-5)
$1K–$15K · Traded Apr 14, 2025 · disclosed Jan 13, 2026 · filed 274 days later
- Sep 12, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Aug 5, 2025 · disclosed Sep 12, 2025
- Sep 12, 2025$1K–$15K
Rep. Val T. Hoyle (D-OR-4)
$1K–$15K · Traded Oct 29, 2024 · disclosed Sep 12, 2025 · Spouse · filed 318 days later
- Sep 3, 2025$100K–$250K
- Sep 3, 2025$1K–$15K
- Sep 3, 2025$15K–$50K
- Aug 5, 2025$15K–$50K
- Aug 5, 2025$15K–$50K
- Aug 5, 2025$1K–$15K
- Aug 5, 2025$15K–$50K
- Aug 5, 2025$15K–$50K
- Aug 5, 2025$15K–$50K
- Jun 22, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded May 12, 2025 · disclosed Jun 22, 2025
- Jun 9, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded May 15, 2025 · disclosed Jun 9, 2025
- Jun 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded May 30, 2025 · disclosed Jun 6, 2025
- May 8, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Apr 8, 2025 · disclosed May 8, 2025
- May 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Apr 29, 2025 · disclosed May 6, 2025
- Apr 11, 2025$15K–$50K
Rep. Jefferson Shreve (R-IN-6)
$15K–$50K · Traded Mar 5, 2025 · disclosed Apr 11, 2025
- Apr 7, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Mar 31, 2025 · disclosed Apr 7, 2025
- Aug 16, 2024$1K–$15K
Rep. Kathy E. Manning (D-NC-6)
$1K–$15K · Traded Jul 2, 2024 · disclosed Aug 16, 2024 · Spouse
- Aug 16, 2024$1K–$15K
Rep. Kathy E. Manning (D-NC-6)
$1K–$15K · Traded Jul 2, 2024 · disclosed Aug 16, 2024 · Spouse
- Aug 13, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Jul 12, 2023 · disclosed Aug 13, 2023
- Jul 12, 2023$1K–$15K
Rep. Earl Blumenauer (D-OR-3)
$1K–$15K · Traded Jun 15, 2023 · disclosed Jul 12, 2023 · Spouse
- May 19, 2023$1K–$15K
Rep. Kathy E. Manning (D-NC-6)
$1K–$15K · Traded Apr 28, 2023 · disclosed May 19, 2023
- May 19, 2023$1K–$15K
Rep. Kathy E. Manning (D-NC-6)
$1K–$15K · Traded Apr 28, 2023 · disclosed May 19, 2023 · Spouse
- May 19, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Apr 10, 2023 · disclosed May 19, 2023
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Feb 24, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.